Study reveals obesity’s impact on muscle structure in heart failure with preserved ejection fraction

A new small study led by Johns Hopkins Medicine researchers and published July 25th in the journal Nature Cardiovascular Research has revealed the impact of obesity on muscle structure in patients having a form of heart failure called heart failure with a preserved ejection fraction (HFpEF).

ASCO 2024: Novartis’ Scemblix outperforms standard of care in CML

Novartis’ Scemblix generated $136m in sales in Q1 this year, as per the company’s financials. Image Credit: Taljat David / Shutterstock. Novartis has released positive

May 31, 2024

Medicaid expansion associated with reduction in early mortality after lung cancer surgery

In a new, national, hospital-based study, researchers at the American Cancer Society (ACS) found that Medicaid expansion was associated with a statistically significant reduction in

January 16, 2024

Risk adjusted net present value: What is the current valuation of Jazz Pharmaceuticals’s JZP-898?

JZP-898 is a fusion protein commercialized by Jazz Pharmaceuticals, with a leading Phase I program in Metastatic Renal Cell Carcinoma;Metastatic Transitional (Urothelial) Tract Cancer.

December 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.